<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Difference_Between_Protein_Kinase_And_Tyrosine_Kinase</id>
		<title>Difference Between Protein Kinase And Tyrosine Kinase - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Difference_Between_Protein_Kinase_And_Tyrosine_Kinase"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Difference_Between_Protein_Kinase_And_Tyrosine_Kinase&amp;action=history"/>
		<updated>2026-05-03T20:46:24Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Difference_Between_Protein_Kinase_And_Tyrosine_Kinase&amp;diff=175897&amp;oldid=prev</id>
		<title>Snakescene4: Створена сторінка: M, Craig HM, Petersen-Mahrt SK, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803809. Mariani R, Chen D, Schrofelbauer B, N...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Difference_Between_Protein_Kinase_And_Tyrosine_Kinase&amp;diff=175897&amp;oldid=prev"/>
				<updated>2017-05-12T17:48:05Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: M, Craig HM, Petersen-Mahrt SK, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803809. Mariani R, Chen D, Schrofelbauer B, N...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;M, Craig HM, Petersen-Mahrt SK, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803809. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, et al. SpeciesSpecific Exclusion of APOBEC3G from HIV-1 Virions by Vif. Cell 114: 2131. Yu Q, Konig R, [http://www.medchemexpress.com/LY2606368.html LY-2606368 web] Pillai S, Chiles K, Kearney M, et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination from the HIV genome. Nat Struct Mol Biol 11: 435442. Suspene R, Sommer P, Henry M,  Ferris S, Guetard D, et al. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res 32: 24212429. Guo F, Cen S, Niu M, Saadatmand J, Kleiman L Inhibition of FormulaPrimed Reverse Transcription by Human APOBEC3G for the duration of Human Immunodeficiency Virus Form 1 Replication. J Virol 80: 1171011722. Bishop KN, Holmes RK, Malim MH Antiviral potency of APOBEC proteins will not correlate with cytidine deamination. J Virol 80: 84508458. Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, et al. Human immunodeficiency virus sort 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J Virol 81: 70997110. Luo K, Wang T, Liu B, Tian C, Xiao Z, et al. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus sort 1 integrase and inhibit proviral DNA formation. J Virol 81: 72387248. Kaiser SM, Emerman M Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute towards the antiviral effects with the cytidine deaminase Apobec3G. J Virol 80: 875882. Schrofelbauer B, Yu Q, Zeitlin SG, Landau NR Human immunodeficiency virus type 1 Vpr induces the degradation of [http://www.ncbi.nlm.nih.gov/pubmed/18204824 18204824] the UNG and SMUG uracilDNA glycosylases. J Virol 79: 1097810987. Yang B, Chen K, Zhang C, Huang S, Zhang H Virion-associated Uracil DNA Glycosylase-2 and Apurinic/Apyrimidinic Endonuclease Are Involved in the Degradation of APOBEC3G-edited Nascent HIV-1 DNA. J Biol Chem 282: 1166711675. Yang Y, Guo F, Cen S, Kleiman L Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F. Virology 365: 92100. Luo K, Ehrlich E, Xiao Z, Zhang W, Ketner G, et al. Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53. Faseb J 21: 17421750. Yu X, Yu Y, Liu B, Luo K, Kong W, et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complicated. Science 302: 10561060. Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D Phosphorylation of a novel SOCS-box regulates assembly in the HIV-1 Vif-Cul5 complicated that promotes APOBEC3G degradation. Genes Dev 18: 28612866. Stopak K, de Noronha C, Yonemoto W, Greene WC HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing each its translation and intracellular stability. Mol Cell 12: 591601. Marin M, Rose KM, Kozak SL, Kabat D HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9: 13981403. Conticello SG, Harris RS, Neuberger MS The Vif protein of HIV triggers degradation from the human antiretroviral DNA deaminase APOBEC3G. Curr Biol 13: 20092013. Sheehy AM, Gaddis NC, Malim MH The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9: 14041407. Liu B, Yu X, Luo K, Yu Y, Yu XF Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus form 1 virion packaging of APOBEC3G. J&lt;/div&gt;</summary>
		<author><name>Snakescene4</name></author>	</entry>

	</feed>